Iron Dextran Patent Expiration

Iron Dextran was first introduced by Sanofi Aventis Us Llc in its drug Iron Dextran on Approved Prior to Jan 1, 1982. Other drugs containing Iron Dextran are Infed, Proferdex, Dexferrum. 4 different companies have introduced drugs containing Iron Dextran.


Iron Dextran Patents

Given below is the list of patents protecting Iron Dextran, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Dexferrum US5624668 Iron dextran formulations Sep 29, 2015

(Expired)

Am Regent



Iron Dextran's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Iron Dextran Generic API Manufacturers

Given below is the list of companies who have filed for Iron Dextran generic, along with the locations of their manufacturing plants worldwide.